Search
for
Sort by
Research 22
- Non-viral delivery of the CRISPR/Cas system: DNA<i>versus</i>RNA<i>versus</i>RNP
- Long non-coding RNA Xist contribution in systemic lupus erythematosus and rheumatoid arthritis
- Primary scarring alopecias. A literature review
- Delivery of Tissue-Targeted Scalpels: Opportunities and Challenges for <i>In Vivo</i> CRISPR/Cas-Based Genome Editing
- Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men
- Collagen-Heparin-FGF2-VEGF Scaffolds Induce a Regenerative Gene Expression Profile in a Fetal Sheep Wound Model
- Association Between Human Hair Loss and the Expression Levels of Nucleolin, Nucleophosmin, and<i>UBTF</i>Genes
- All Roads Go to the Nucleus: Integration of Signaling/Transcription Factor-Mediated and Epigenetic Regulatory Mechanisms in the Control of Skin Development and Regeneration
- Advances in Chitosan-Based Nanoparticles for Drug Delivery
- Engineered extracellular vesicles for tissue repair and regeneration
- Intelligent nanotherapeutic strategies for the delivery of CRISPR system
- Strategies for High-Efficiency Mutation Using the CRISPR/Cas System
- Innate type 2 immunity controls hair follicle commensalism by Demodex mites
- Current and prospective strategies for advancing the targeted delivery of CRISPR/Cas system via extracellular vesicles
- Stimuli-responsive nanoformulations for CRISPR-Cas9 genome editing
- Single-cell analysis of temporal immune cell dynamics in alopecia areata reveals a causal role for clonally expanded CD8+ T cells in disease
- Recent Advances in Genome-Editing Technology with CRISPR/Cas9 Variants and Stimuli-Responsive Targeting Approaches within Tumor Cells: A Future Perspective of Cancer Management
- Nano-Enabled CRISPR-Cas Gene Editing for Cancer Therapeutics
- Microbial allies in skin trauma recovery: from immune modulation to engineered probiotic therapeutics
- Profibrotic Molecules Are Reduced in CRISPR-Edited Emery–Dreifuss Muscular Dystrophy Fibroblasts
- Design of Liposome Formulations for CRISPR/Cas9 Enzyme Immobilization: Evaluation of 5-Alpha-Reductase Enzyme Knockout for Androgenic Disorders
- New frontiers in CRISPR/Cas9 delivery systems delivery for gene editing